(Q45865376)

17 December 2017

title

Cancer gene therapy: the power of negative thinking (English)

1 reference

17 December 2017

0 references

1 reference

Lotze MT

1 reference

17 December 2017

language of work or name

1 reference

1 February 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

1 reference

17 December 2017

issue

1 reference

17 December 2017

page(s)

191-193

1 reference

17 December 2017

Modelling the molecular circuitry of cancer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Unraveling biologic therapy for Bcl-2-expressing malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Lymphocytes as cellular vehicles for gene therapy in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Viruses as gene delivery vectors: application to gene function, target validation, and assay development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

TGF-beta inhibitors for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Telomerase-dependent oncolytic adenovirus for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Addicted to death: invasive cancer and the immune response to unscheduled cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

Trials and Tribulations: The Cost of Developing Gene Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

1 reference

7 January 2021

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

7 January 2021

Inflammation and necrosis promote tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

7 January 2021

Viral oncolysis: tumor-tailored therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302633

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302633

1 reference

17 December 2017

Dimensions Publication ID

1001195824

0 references

1 reference

17 December 2017